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Regulation of Tissue-Dependent Differences in CD8 T Cell
Apoptosis during Viral Infection
Varun N. Kapoor, Hyun Mu Shin, Ok Hyun Cho, Leslie J. Berg, Joonsoo Kang, Raymond M. Welsh
Department of Pathology, Program in Immunology and Virology, University of Massachusetts Medical School, Worcester, Massachusetts, USA
ABSTRACT
Virus-specific CD8 T cells in the lymphoid organs contract at the resolution of virus infections by apoptosis or by dissemina-
tion into peripheral tissues, and those residing in nonlymphoid organs, including the peritoneal cavity and fat pads, are more
resistant to apoptosis than those in the spleen and lymph nodes. This stability of memory T cells in the nonlymphoid tissues may
enhance protection to secondary challenges. Here, we show that lymphocytic choriomeningitis virus (LCMV)-specific CD8 T
cells in nonlymphoid tissues were enriched for memory precursors (expressing high levels of interleukin-7 receptor and low lev-
els of killer cell lectin-like receptor G1 [IL-7Rhi KLRG1lo]) and had higher expression of CD27, CXCR3, and T cell factor-1 (TCF-
1), each a marker that is individually correlated with decreased apoptosis. CD8 T cells in the peritoneal cavity of TCF-1-defi-
cient mice had decreased survival, suggesting a role for TCF-1 in promoting survival in the nonlymphoid tissues. CXCR3 CD8
T cells resisted apoptosis and accumulated in the lymph nodes of mice treated with FTY720, which blocks the export of lymph
node cells into peripheral tissue. The peritoneal exudate cells (PEC) expressed increased amounts of CXCR3 ligands, CXCL9 and
CXCL10, which may normally recruit these nonapoptotic cells from the lymph nodes. In addition, adoptive transfer of splenic
CD8 T cells into PEC or spleen environments showed that the peritoneal environment promoted survival of CD8 T cells.
Thus, intrinsic stability of T cells which are present in the nonlymphoid tissues along with preferential migration of apoptosis-
resistant CD8 T cells into peripheral sites and the availability of tissue-specific factors that enhance memory cell survival may
collectively account for the tissue-dependent apoptotic differences.
IMPORTANCE
Most infections are initiated at nonlymphoid tissue sites, and the presence of memory T cells in nonlymphoid tissues is critical
for protective immunity in various viral infection models. Virus-specific CD8 T cells in the nonlymphoid tissues are more resis-
tant to apoptosis than those in lymphoid organs during the resolution andmemory phase of the immune response to acute
LCMV infection. Here, we investigated the mechanisms promoting stability of T cells in the nonlymphoid tissues. This increased
resistance to apoptosis of virus-specific CD8 T cells in nonlymphoid tissues was due to several factors. Nonlymphoid tissues
were enriched in memory phenotype CD8 T cells, which were intrinsically resistant to apoptosis irrespective of the tissue envi-
ronment. Furthermore, apoptosis-resistant CD8 T cells preferentially migrated into the nonlymphoid tissues, where the avail-
ability of tissue-specific factors may enhance memory cell survival. Our findings are relevant for the generation of long-lasting
vaccines providing protection at peripheral infection sites.
Programmed cell death, mostly in the form of apoptosis, is crit-ical for regulating viral pathogenesis and the host immune
response during viral infections. Several viruses can firstmodulate
the apoptotic machinery to promote viral replication within cells
by inhibiting apoptosis and then promote dissemination of virus
by triggering apoptosis (1). The immune response to virus infec-
tions is also regulated by apoptotic events. Interferon (IFN)-
driven apoptosis ofmemory T cells during early stages of lympho-
cytic choriomeningitis virus (LCMV) infection opens up space in
the immune system and allows for generation of a diverse T cell
response (2, 3), whereas apoptosis of virus-specific effector T cells
after the peak of the immune response is essential for curtailing
the response and restoring immune homeostasis upon clearance
of the viral antigens (4, 5). At this later time, a small population of
virus-specific T cells escapes apoptosis and forms memory cells
that provide long-lived immunity. Our laboratory has previously
shown that during this transition from the acute to the memory
phase of the immune response, LCMV-specific CD8 T cells in
the peripheral nonlymphoid tissues, including peritoneal cavity,
fat pads, and lungs, are more resistant to apoptosis than those in
the spleen and lymph nodes, and these differences persist for sev-
eral months thereafter (6). Infections by a number of viruses are
initiated at nonlymphoid tissue sites, and tissue-resident memory
T cells have been shown to be important in mediating protection
against secondary virus challenges (7–10). Therefore, this resis-
tance to apoptosis may provide a mechanism by which protective
memory CD8 T cells could persist in nonlymphoid organs.
CD8 T cells generated during the course of an immune re-
sponse are heterogeneous and express phenotypic markers, such
as interleukin-7 receptor (IL-7R), killer cell lectin-like receptorG1
(KLRG1), CD27, and CXCR3 that characterize their activation
state and portend their conversion into memory cells. CD8 T
cells that express high levels of IL-7R (IL-7Rhi) and low levels of
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KLRG1 (KLRG1lo) are defined as memory precursor effector cells
(MPEC), are capable of self-renewal, and can provide long-term
protection against reinfection (11–13). CD27 belongs to the tu-
mor necrosis factor receptor (TNFR) family and has also been
used as amarker to identify memory precursor CD8 T cells (12).
Expression of CD27 on virus-specific CD8 T cells promotes sur-
vival, induces IL-7R expression, and protects against Fas-depen-
dent apoptosis (14–17). CD27-CD70 interactions have been
shown to induce autocrine IL-2 production in CD8 T cells,
thereby promoting their survival (18). Activated T cells may also
express CXCR3, a chemokine receptor required for T cell che-
motaxis to the site of antigen (19, 20). Moreover, individual ex-
pression of IL-7R, CD27, and CXCR3 has been used to identify
memory CD8 T cell populations with an efficient recall response
(21). Whether expression of these phenotypic markers correlates
with tissue-dependent differences in apoptosis during resolution
of the immune response has not been clarified.
Differences inCD8T cell transcriptional regulationmay con-
tribute to differential survival of CD8 T cells in tissue environ-
ments, but few transcription factors regulating the fate of CD8 T
cell effector-memory generation have been identified. T cell fac-
tor-1 (TCF-1; encoded by Tcf7) is a transcription factor acting
downstream in the Wnt signaling pathway (22). Apart from its
role in thymocyte differentiation (23), TCF-1 was shown to be
important for promoting generation andmaintenance ofmemory
CD8 T cells (24, 25) as TCF-1-deficient CD8 T cells had im-
paired expansion after a secondary antigen challenge (24–26).
TCF-1 deficiency was associated with decreased expression of an-
other transcription factor, eomesodermin (Eomes), and the loss of
proliferation driven by IL-15, whose receptor is regulated by the
transcription factor Eomes (25). However, the contribution of
TCF-1 in the resistance of CD8 T cells to apoptosis in different
tissue environments during resolution of the immune response
has not been tested.
T cells are initially activated in the spleen and lymph nodes,
after which they migrate to nonlymphoid tissues to eliminate for-
eign antigens (27). Activated T cells express chemokine receptors
that guide their migration to sites of antigen. CXCR3 is a chemo-
kine receptor expressed on activated Th1 CD4 T cells and on
effector CD8 T cells (19), and it promotes migration of activated
CD8 T cells into nonlymphoid tissue infection sites under the
influence of its chemokine ligands CXCL9 and CXCL10 (28, 29).
Our present study examines themechanisms bywhichCD8T
cells preferentially survive in the nonlymphoid tissues. We show
here that nonlymphoid tissues were enriched in memory pheno-
type CD8 T cells intrinsically resistant to apoptosis, irrespective
of the tissue environment. Furthermore, we show that apoptosis-
resistant CD8 T cells may preferentially migrate into the non-
lymphoid tissues where the availability of tissue-specific factors
may enhance memory cell survival.
MATERIALS AND METHODS
Mice. C57BL/6J male mice were purchased from the Jackson Laboratory
(Bar Harbor, ME). P14 transgenic mice were bred onto CD90.1 (Thy1.1)
andCD45.1 (Ly5.1) C57BL/6 backgrounds to distinguish the transgenic T
cells from wild-type (WT) cells in the C57BL/6 (CD90.2 [Thy1.2]
CD45.2 [Ly5.2]) mice. Tcf7/mice on the C57BL/6 background have
been described previously (30) and were bred at the University of Massa-
chusetts Medical School (UMMS). Tcf7/ littermate mice were used as
WT controls. The LCMV glycoprotein GP61-80-specific CD4 transgenic
SMARTA CD45.1 mice (31) were bred at UMMS. Mice were bred and
housed under specific-pathogen-free conditions at the UMMS in accor-
dance with the guidelines of the Institutional Animal Care and Use Com-
mittee of UMMS (IACUC).
Preparation of leukocytes. Mice were sacrificed by cervical disloca-
tion. Peritoneal exudate cells (PEC) were collected by lavage with 10ml of
coldRPMI 1640medium (Gibco). Spleen, lymphnodes, and fat padswere
ground between glass microscope slides to prepare single-cell suspen-
sions. To remove contaminating erythrocytes, leukocyte preparations
were treated with 0.84% ammonium chloride (NH4Cl).
Virus. LCMV, strain Armstrong, was propagated in BHK cells as pre-
viously described (32). Mice were inoculated intraperitoneally (i.p.) with
0.1 ml containing 5 104 PFU in phosphate-buffered saline (PBS).
Antibodies, flow cytometry, and intracellular cytokine staining.
Leukocytes were stained for CD8 (53-6.7; BD Pharmingen), CD8
(YTS156.7.7; Biolegend), CD4 (RM4-5; BD Pharmingen), CD44 (IM7;
eBiosciences), Thy1.1/CD90.1 (HIS51; eBiosciences), Ly5.1/CD45.1
(A20; Biolegend), KLRG1 (2F1; eBiosciences), CD127 (A7R34; eBio-
sciences), CD27 (LG.310; BD Pharmingen), CXCR3 (CXCR3-173;
Biolegend), CXCL9 (MIG-2F5.5; eBiosciences), TCF-1 (C63D9; Cell
Signaling), Eomes (Dan11mag; eBiosciences), Bcl-2 (3F11; BD Phar-
mingen), CD122 (TM.BETA-1; BD Pharmingen), and CD70 (FR70;
Biolegend). For TCF-1 intracellular staining Alexa Fluor 647-conju-
gated goat anti-rabbit (Invitrogen) secondary antibody was used. To
stain for intracellular antigens a FOXP3/transcription factor staining
buffer kit (eBiosciences) was used. For intracellular cytokine secretion
assays, leukocytes were incubated for 5 h ex vivo with a 1 M concen-
tration of an LCMV-specific nucleoprotein peptide comprised of res-
idues 396 to 404 (NP396–404), GP peptide comprised of residues 33 to
41 (GP33–41), or GP61–80 peptide in the presence of Golgi Plug (BD
Biosciences). Cells were then permeabilized using a Cytofix/Cytoperm
kit (BD Biosciences), followed by intracellular staining for IFN-
(XMG1.2; eBiosciences), IL-2 (JES65H4; BD Pharmingen), and TNF
(MP6-XT22; Biolegend). Fluorescence-activated cell sorting (FACS)
plots were gated on 7-amino-actinomycin D-negative (7-AAD) cells
versus forward scatter area (FSC-A; live), on forward scatter height
(FSC-H) versus FSC-A (singlets), on FSC-A versus side scatter area
(SSC-A) (lymphocytes), and then on the population of interest. Sam-
ples were analyzed on an LSRII flow cytometer (Becton, Dickinson),
and data were further analyzed using FlowJo software (Tree Star).
AnnexinV,TUNEL, and caspase-3 assay.Leukocyteswere stained for
Annexin V (eBiosciences), and samples were analyzed live according to
the manufacturer’s protocol. 7-AAD (BD Pharmingen) was used to gate
out dead and late-apoptotic populations. For terminal deoxynucleotidyl-
transferase-mediated dUTP-biotin nick end labeling (TUNEL) and active
caspase-3 staining, leukocytes were incubated at 37°C directly ex vivo for 5
h in culture medium. The TUNEL assay (Apo-Direct Kit; BD Pharmin-
gen) and active caspase-3 (C92-605; BD Pharmingen) staining were car-
ried out according to the manufacturer’s protocol. For active caspase-3
and TCF-1 costaining, after samples were stained with rabbit TCF-1 pri-
mary and goat anti-rabbit secondary antibody, they were incubated with
unlabeled rabbit IgG (Southern Biotech) to saturate the goat anti-rabbit
secondary antibody. Cells were then incubated with rabbit active
caspase-3 antibody. For inhibiting caspase-dependent apoptosis, leuko-
cytes were cultured for 5 h ex vivo in the presence of 100MZ-VAD-FMK
(carboxybenzyl-Val-Ala-Asp-fluoromethylketone; Enzo Life Sciences).
Adoptive transfer studies and cell labeling. Unless otherwise noted,
virus-specific CD8 T cell responses were tracked by transferring 2 105
P14 splenocytes (CD90.1 or CD45.1) into congenic C57BL/6 hosts
(CD90.2 CD45.2). Splenocytes from day 7 LCMV-infected mice were
labeled with 2 M carboxyfluorescein succinimidyl ester (CFSE) or 0.5
M DDAO [7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-2-one)],
washed, and adoptively transferred into an infection-matched C57BL/6
host as shown in Fig. 6A.
Apyrase and FTY720 treatment.Day 7 LCMV-infectedmice were i.p.
injected with 5 U of apyrase (New England BioLabs) or succinate buffer
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control and were sacrificed after 6 h. FTY720 (Cayman Chemical Com-
pany) at 1mg/kgwas given intravenously (i.v.) (days 5 and 6) and i.p. (day
7) post-LCMV infection as shown in Fig. 5A.
RT-PCR. Total RNA was isolated using an RNeasy minikit (Qiagen),
converted to cDNA (Quantitect reverse transcription kit; Qiagen), and
analyzed by real-time quantitative PCR amplification on a Bio-Rad
iCycler by using a Quanti-Fast RT-PCR SYBR green kit (Qiagen), accord-
ing to themanufacturer’s protocol. Primers forCxcl9,Cxcl10, and-actin
were purchased from Qiagen.
Statistical analysis. Data significance (P values) was calculated using
an unpaired Student’s t test. All error bars in the manuscript represent
standard deviations (SD) from the means.
RESULTS
CD8 T cells in the nonlymphoid tissues are resistant to apop-
tosis. LCMV-specific CD8 T cells in the nonlymphoid tissues
(liver [otherwise considered a graveyard for apoptotic T cells],
lung, fat pad, and peritoneal cavity) were previously shown to
react less with the preapoptotic marker annexin V (6, 33, 34) than
those in spleen and lymphoid organs, and splenocytes that reacted
with annexinV failed to develop intomemory cells (35).However,
because annexin V can also bind at some level to activated and
proliferating T cells (36, 37), we reassessed bona fide end-stage
apoptotic cells within cells from representative organs using the
FIG 1 Virus-specific CD8 T cells in the nonlymphoid tissues are resistant to apoptosis. (A) Annexin V reactivity of viable 7-AAD P14 CD8 T cells in
lymphoid (spleen, inguinal lymphnodes [ILN],mesenteric lymphnodes [MLN]) andnonlymphoid (PEC and fat pad) tissues at day 9 post-LCMV infection. Five
mice were used for the experiment, and the experiment was done three times. Mean fluorescence intensity (MFI) for annexin V reactivity of P14 CD8 T cells
is depicted in each histogram. Annexin V reactivity of spleen, inguinal lymph nodes, andmesenteric lymph nodes was significantly different from that in the PEC
or fat pads (P	 0.0001). (B) Lymphocytes from lymphoid (spleen, inguinal lymph nodes, and mesenteric lymph nodes) and nonlymphoid (PEC and fat pad)
tissues were isolated at day 9 post-LCMV infection and cultured ex vivo for 5 h postisolation. TUNEL reactivity of P14 CD8 T cells is represented in the
histograms. Fivemicewere used for the experiment, and the experimentwas done three times. TUNEL reactivity of spleen, inguinal lymphnodes, andmesenteric
lymph nodes was significantly different from that in the PEC or fat pads (P	 0.0001). (C) Lymphocytes from spleen and PECwere isolated at day 9 post-LCMV
infection and cultured ex vivo for 5 h postisolation. Values in histograms are percentages 
 SD of P14 CD8 T cells reactive with active caspase-3. The
experiment was done three times with 3 mice in each experiment. (D) Splenocytes isolated at day 9 postinfection were cultured for 5 h ex vivo in presence or
absence of Z-VADFMK.Values in histograms are percentages
 SD of P14CD8T cells reactive in the TUNEL assay. The experiment was done two times with
3 mice in each experiment. (E) Overlay of Bcl-2 expression (left) in P14 CD8 T cells in the PEC (red), spleen (blue) or isotype control (green, PEC isotype;
orange, spleen isotype) at day 9 post-LCMV infection.MFIs of Bcl-2 expression in P14CD8T cells in PEC and spleen (SPL) are shown in the histogram (right).
The experiment was done two times with 3 mice in each experiment. (F and G) Absolute number and percentage of P14 CD8 T cells at day 8, 9, 15, and 20
post-LCMV infection. Data are from 5mice for days 8, 15, and 20 and from 3mice for day 9, and the experiment was done two times. Percentages and error bars
are represented
 SD.
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TUNEL assay to detect fragmented DNA in addition to the an-
nexin V assay to detect membrane changes (Fig. 1A and B).
Splenocytes from P14 transgenic mice (harboring CD8 T cells
specific for the LCMV GP33–41 epitope) were adoptively trans-
ferred into a congenic C57BL/6 host, followed by infection with
LCMV strain Armstrong. At day 9 post-LCMV infection, lym-
phoid (spleen, inguinal lymph nodes, and mesenteric lymph
nodes) and nonlymphoid (fat pad and PEC) tissues were har-
vested. Detection of end-stage apoptotic cells directly ex vivo is
difficult as most of them are efficiently cleared in vivo by phago-
cytes (38). We therefore cultured cells directly ex vivo for 5 h to
detect TUNEL-positive (TUNEL) end-stage apoptotic cells. In
accordance with our previous observations, we found that at day 9
post-LCMV infection, virus-specific CD8 T cells in the nonlym-
phoid tissues, including the peritoneal cavity and fat pad, were
more resistant to apoptosis and less reactive with TUNEL than
those in the lymphoid organs, including spleen, inguinal lymph
nodes, and mesenteric lymph nodes (Fig. 1B).
These tissue-dependent apoptotic differences persisted up to at
least 4 months post-LCMV infection, as detected by annexin V
assays (data not shown).
Levels of activated caspase-3 increase in apoptotic T cells (39),
and T cells from caspase-3-deficient mice have reduced suscepti-
bility to activation-induced cell death (AICD) driven by CD3
cross-linking and Fas ligands (40). To test whether increased
apoptosis of virus-specific CD8 T cells in lymphoid organs cor-
related with increased caspase-3 activation, virus-specific CD8T
cells fromday 9 LCMV-infected PEC or spleenwere cultured for 5
h directly ex vivo and stained for active caspase-3. Consistent with
the increased apoptosis, virus-specific CD8 T cells in spleen also
had higher levels of active caspase-3 than PEC (Fig. 1C). To con-
firm that the CD8 T cell apoptosis was caspase dependent, day 9
splenocytes from LCMV-infected mice were incubated in the
presence of the pan-caspase inhibitor ZVAD-FMK. The virus-
specific CD8 T cells from the spleen were less TUNEL reactive
when incubated in the presence of ZVAD-FMK, suggesting that
the CD8 T cell apoptosis required caspases (Fig. 1D).
Cellular apoptosis results from the interplay between pro- and
antiapoptotic factors, and higher levels of the antiapoptotic Bcl-2
in effector CD8 T cells have been shown to be important in
counteracting the effects of proapoptotic Bim, thereby allowing
survival of cells during contraction of the immune response (41).
Activated virus-specific CD8 T cells that become memory cells
also express higher levels of Bcl-2 (42). Virus-specificCD8T cells
in the PEC expressed higher levels of Bcl-2 than those from the
spleen during the resolution of the immune response (Fig. 1E).
These results collectively show by several criteria that virus-spe-
cific CD8 T cells in the peripheral tissues are more resistant to
apoptosis than those in the lymphoid organs.
We hypothesized that the decreased apoptosis in the perito-
neum would lead to increased survival and stability of virus-spe-
cific CD8T cells during contraction of the immune response. To
test this hypothesis, the kinetics of the virus-specific T cell re-
sponsewere analyzed in the spleen and PEC at days 8, 9, 15, and 20
post-LCMV infection. Consistent with their resistance to apopto-
sis, by day 20 virus-specific CD8 T cells in the peritoneum had
reduced contraction (5.2-fold decrease from the peak at day 8)
compared to T cell populations in the spleen (25.5-fold decrease
from the peak at day 8) (Fig. 1F). Furthermore, the peritoneal
cavity maintained a higher proportion of virus-specific CD8 T
cells than the spleen through day 20 post-LCMV infection (Fig. 1G).
These results show that decreased T cell apoptosis leads to in-
creased T cell stability in the peritoneal environment, allowing the
generation of memory T cell populations which may be able to
productively respond to a secondary challenge.
Nonlymphoid tissues are enriched for apoptosis-resistant
memory phenotype CD8 T cells. Antigenic characterizations
were employed to determine why CD8 T cells in the peripheral
tissues were more resistant to apoptosis. Higher proportions of
virus-specific CD8 T cells with an MPEC phenotype (IL-7Rhi
KLRG1lo) were present in the nonlymphoid tissues than in lym-
phoid organs at day 8 post-LCMV infection (Fig. 2A), and this
pattern still persisted at day 40 post-LCMV infection (day 40, 62%
IL-7Rhi KLRG1lo in PEC versus 37% IL-7Rhi KLRG1lo in spleen
[data representative of pooled samples from five mice]). Cells ex-
pressing large amounts of IL-7-R have been shown to express
more Bcl-2 and to be relatively resistant to apoptosis (11, 35).
Stimulation of CD27 on CD8 T cells in vitro has been shown to
promote survival (16, 17), and in vivo blockade of CD27 promotes
apoptosis of virus-specific CD8 T cells (15). Correspondingly,
higher proportions of virus-specific CD8 T cells in the PEC ex-
pressed CD27 than in the spleen (Fig. 2B). To confirm that CD27
expression on CD8 T cells promotes survival, we compared
apoptotic profiles of CD27hi and CD27lo CD8 T cells. Levels of
TUNEL and active caspase-3 reactivity revealed that at day 8 after
LCMV infection virus-specific CD27hi CD8 T cells were less
apoptotic than theCD27lo populations in both the spleen andPEC
(Fig. 2B). CXCR3 is another marker preferentially expressed on
memory phenotype CD8 T cells. At day 8 post-LCMV infection,
a higher proportion of CXCR3-expressing virus-specific CD8 T
cells were present in PEC than in the spleen (Fig. 2C). Levels of
TUNEL and active caspase-3 reactivity revealed that virus-specific
CXCR3hi CD8T cells were less apoptotic than the CXCR3lo pop-
ulations in both spleen and PEC (Fig. 2C). Therefore, by several
criteria, memory T cells resistant to apoptosis were present at a
higher frequency in PEC than in spleen. Moreover, during reso-
lution of the immune response, CD27 and CXCR3 expression on
CD8 T cells correlated with decreased apoptosis.
The ability of virus-specific CD8 T cells to produce multiple
cytokines, such as IFN-, TNF, and IL-2, simultaneously during
viral infection is a primary indicator of their functional capacity,
and IL-2-producing CD8 T cells are more likely to become
memory cells than those that do not make IL-2 (43). We thus
examined the cytokine repertoire of virus-specific CD8 T cells
isolated from PEC and spleen. On stimulation with LCMV-spe-
cific GP33–41 andNP396–404 peptide epitopes, virus-specific CD8

T cells from PEC were enriched in IFN-, TNF, and IL-2 triple
producers compared to the spleen (Fig. 2D). Moreover, CD27-
and CXCR3-expressing virus-specific CD8 T cells were enriched
in IL-2 producers, suggesting that expression of these markers
represented CD8 T cells that could become memory cells (data
not shown). Overall, these results indicated that the nonlymphoid
tissues are enriched in memory precursor T cells that are intrinsi-
cally resistant to apoptosis.
TCF-1 promotes survival of CD8 T cells in the peritoneum
during resolutionof the immuneresponse.Transcription factors
in addition to cell surface antigens were assessed as correlates of
resistance to apoptosis. TCF-1 is a transcription factor which pro-
motes generation and maintenance of functional memory CD8
T cells (24, 25, 26). Since the nonlymphoid tissue environment
Regulation of Tissue-Dependent CD8 T Cell Apoptosis
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was enriched inmemory phenotype CD8 T cells, we determined
TCF-1 expression in the T cells from PEC as representative of
nonlymphoid tissues and from spleen as a representative of lym-
phoid organs. At day 9 post-LCMV infection, a higher proportion
of virus-specific and activated CD44hi CD8 T cells expressed
TCF-1 in the PEC than in the spleen (Fig. 3A). The expression level
of TCF-1 was also higher in virus-specific and activated CD44hi
CD8 T cells in PEC than in spleen, as shown by the mean fluo-
rescence intensity (MFI) (Fig. 3A). Virus-specific CD8 T cells in
PEC continued to have higher expression of TCF-1 at day 30 post-
LCMV infection than in spleen (Fig. 3A). TCF-1 deficiency has
been shown to limit the generation of CD44hi CD62Lhi (central
memory) CD8 T cells (25). Virus-specific CD8 T cells in the
spleen and PEC expressing large amounts of TCF-1 were enriched
in MPEC, with most expressing CD27 and CXCR3 (Fig. 3B and
C). Cells expressing high levels of TCF-1 (TCF-1hi) were also less
apoptotic, as revealed by low levels of active caspase-3 staining
(Fig. 3B and C). Overall, these results demonstrate that the PEC
environment was enriched in TCF-1hi CD8 T cells and that this
correlated with increased memory and increased survival. TCF-1
has been shown to be necessary and sufficient for expression of
Eomes, a transcription factor associated with memory CD8 T
cells (25). Correspondingly, there was a higher expression of
Eomes in virus-specific CD8 T cells in the PEC than in spleen at
day 9 post-LCMV infection (MFI of Eomes on P14CD8 T cells
of 362
 7.5 for spleen versus 524
 21 for PEC).
Since a higher proportion of virus-specific CD8 T cells in the
PEC expressed TCF-1, we next sought more direct evidence to
identify whether TCF-1was promoting survival of CD8T cells in
the nonlymphoid tissues. In accordancewith previous reports (24,
25), TCF-1-deficient mice at day 9 postinfection had a decreased
proportion and absolute number of activated CD44hi CD8 T
cells in both PEC and spleen (data not shown). Interestingly, the
proportion ofMPEC in the CD44hi CD8 T cell pool was reduced
to far lower levels in the PEC than in the spleen in the TCF-1-
deficient mice at day 9 postinfection (Fig. 4A). To test whether
FIG 2 Higher percentage of MPEC and CD27- and CXCR3-expressing cells in the PEC and their resistance to apoptosis. (A) P14 CD8 T cells in lymphoid
(spleen, inguinal lymph nodes [ILN], mesenteric lymph nodes [MLN]) and nonlymphoid (PEC and fat pad) tissues at day 8 post-LCMV infection were stained
for IL-7R andKLRG1. Leukocytes from5micewere pooled for the experiment, and the data are a compilation of the results from three independent experiments.
The percentages of memory precursor effector cells (MPEC, top left) or short-lived effector cells (bottom right) are depicted. (B and C) Percentages of
CD27-expressing (B, top) or CXCR3-expressing (C, top) P14 CD8 T cells in PEC or spleen at day 8 post-LCMV infection. At day 8 post-LCMV infection
lymphocytes fromPEC and spleenwere cultured for 5 h directly ex vivo, followed by TUNEL and active caspase-3 staining. TUNEL and active caspase-3 reactivity
of CD27hi or CD27lo (B, bottom) and CXCR3hi or CXCR3lo (C, bottom) P14CD8 T cells in PEC or spleen are represented. Graphs are representative of three
experimentswith 3mice in each experiment. (D)Day 8 LCMV-infected lymphocytes fromPECand spleenwere cultured for 5 h in the presence of LCMV-specific
GP33 andNP396 peptides. Plots are gated on virus-specific CD8 IFN- T cells. Percentages of TNF IL-2 virus-specific CD8 T cells are depicted at the top
right. Graphs are representative of three experiments with 3 mice in each experiment. Percentages and error bars are represented
 SD.
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maintenance of TCF-1 expression promotes survival of CD8 T
cells in the nonlymphoid tissues, WT or TCF-1 knockout (KO)
cells were isolated from spleen and PEC of day 9 LCMV-infected
mice and cultured ex vivo for 5 h, followed by TUNEL staining.
Activated CD44hi CD8T cells from PEC of TCF-1 KOmice were
more apoptotic than those fromWT littermates, with about twice
the number of TUNEL cells (Fig. 4B), and similar results were
also observed by active caspase-3 staining (data not shown). Sup-
porting a previous observation (25), we found no statistically sig-
nificant difference in apoptosis of CD44hi CD8 T cells from
spleen between the TCF-1 KO and WT mice (Fig. 4B). Although
overall numbers and proportions of CD44hi CD8 T cells in
FIG 3 Higher percentage of TCF-1-expressing cells in the PEC and their resistance to apoptosis. (A) Percentages
 SD of TCF-1-expressing P14 CD8 T cells
(left) or CD44hi CD8 T cells (middle) at day 9 (D9) and of P14 CD8 T cells (right) at day 30 post-LCMV infection in PEC and spleen. The MFIs for TCF-1
expression in total day 9 P14CD8 T cells (left) or CD44hi CD8 T cells (middle) and in day 30 P14CD8 T cells (right) are depicted in histograms. Plots are
representative of two experiments with 3 mice in each experiment. (B and C) TCF-1 staining of P14 CD8 T cells from spleen and PEC at day 9 postinfection.
Representative IL-7R, KLRG1, CD27, CXCR3, and active caspase-3 staining in TCF-1hi and TCF-1lo subsets from spleen or PEC is depicted. For panels B and C,
data are representative of two independent experiments, and 5 mice were pooled for each experiment.
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TCF-1 KO mice were reduced in both PEC and spleen, TCF-1
appeared to bemore critical for the survival of CD8 T cells in the
nonlymphoid tissues during resolution of the immune response.
Importantly, CD44hi CD8 T cells in PEC of TCF-1-deficient
mice were still less apoptotic than those in the spleen, suggesting
that additional mechanisms might regulate tissue-dependent dif-
ferences in CD8 T cell apoptosis.
Accumulation of nonapoptotic CXCR3CD8T cells in the
lymph nodes on FTY720 treatment. Experiments were designed
to evaluate whether tissue-dependent differences in CD8 T cell
apoptosis were associated with preferential migration of nonapo-
ptotic CD8 T cells to the nonlymphoid tissues. FTY720 is an
immunosuppressive drug which can modulate trafficking of lym-
phocytes and prevent emigration of T cells from the lymph nodes
into the periphery (44–46). Transgenic P14 CD8 T cells were
adoptively transferred into a congenic host, which was then in-
fected with LCMV. Mice were treated with FTY720 at 1 mg/kg
according to the treatment regimen shown in Fig. 5A. FTY720
treatment was more efficacious in sequestering the T cells in the
lymph nodes than in the spleen; therefore, focus was placed on
lymph nodes for further analysis. There was an increase in abso-
lute number and proportion of virus-specific CD8 T cells in the
inguinal lymph nodes and mesenteric lymph nodes of treated
mice (Fig. 5B and data not shown) and a decrease in absolute
number and proportion of virus-specific CD8 T cells in the PEC
(Fig. 5B). We reasoned that if nonapoptotic CD8 T cells prefer-
entially leave the lymphnodes, blocking their egress should lead to
accumulation of nonapoptotic CD8 T cells in those lymph
nodes. Lymphocytes were thus isolated fromPEC, inguinal lymph
nodes, andmesenteric lymph nodes of day 8 LCMV-infected con-
trol or FTY720-treated mice and cultured ex vivo for 5 h, followed
by TUNEL staining. A lower percentage of virus-specific CD8 T
cells in the inguinal and mesenteric lymph nodes were apoptotic
in the FTY720-treated group than in the control group (Fig. 5C),
and similar results were obtained with active caspase-3 staining
(data not shown). Virus-specific CD8 T cells in the PEC trended
more apoptotic in the FTY720-treated mice than in the control
mice (Fig. 5C). Thus, these data are consistent with the hypothesis
that nonapoptotic CD8 T cells preferentially migrate into non-
lymphoid tissues, andwhenmigration is stopped, these apoptosis-
resistant T cells accumulate in the lymph nodes.
CXCR3 has been shown to be important for migration of an-
tigen-specific CD8T cells into tissue effector sites (19, 28), and it
has been previously reported that the peritoneal cavity is domi-
nated by CXCR3 Th1 CD4 T cells (47). We here have shown
that a higher proportion of virus-specific CD8 T cells expressed
CXCR3 in the PEC and that these were less apoptotic (Fig. 2C).
Figure 5D shows increased proportions of CXCR3 CD8 T cells
accumulating in the inguinal lymph nodes on FTY720 treatment,
suggesting that CXCR3 CD8 T cells were normally preferen-
tially migrating out of the lymph nodes into the nonlymphoid
tissues. CXCR3 T cells migrate under the influence of the IFN-
-inducible chemokine ligands CXCL9 and CXCL10 (19, 20). At
day 8 post-LCMV infection, there was a higher proportion of total
lymphocytes expressing CXCL9 in the PEC environment than in
the spleen (Fig. 5E). Further, mRNA for CXCL9 and CXCL10 was
upregulated 4.7- and 2.6-fold, respectively, in the total PEC lym-
phocytes compared to total splenocytes at day 7 post-LCMV in-
fection (Fig. 5F). Thus, the PEC environment had a higher expres-
sion of CXCR3 ligands that could promote preferential migration
of CXCR3 CD8 T cells. Alternatively, it is also possible that
CXCR3 expression might promote preferential retention of apo-
ptosis-resistant T cells in the peritoneal environment. Overall,
these results are consistent with the hypothesis that nonapoptotic
CXCR3 CD8 T cells may preferentially migrate out of second-
ary lymphoid organs into the nonlymphoid tissues under the in-
fluence of chemokines CXCL9 and CXCL10. This phenomenon
may provide an additional mechanism by which healthy nonapo-
ptotic memory CD8 T cells populate nonlymphoid tissues to
provide protection to secondary challenge.
In vivoPEC environment promotes survival of CD8T cells.
To test whether the in vivo PEC environment itself had any effect
on promoting survival of CD8 T cells, LCMV-specific P14
CD8 T cells were adoptively transferred into congenic hosts, fol-
lowed by LCMV infection. At day 7 postinfection, splenocytes
were isolated and labeled with tracking dyes CFSE or DDAO and
FIG 4 TCF-1 promotes survival of CD8 T cells in nonlymphoid tissues. (A) Percentage of IL-7R- and KLRG1-expressing CD44hi CD8 T cells in PEC and
spleen of WT or TCF-1 KO mice at day 9 post-LCMV infection. Numbers represent percentages 
 SD of IL-7Rhi KLRG1lo CD8 T cells. Graphs are
representative of four experiments with at least 3 mice in each experiment. (B) Lymphocytes from spleen and PEC were isolated at day 9 post-LCMV infection
fromWT and TCF-1 KOmice and cultured ex vivo for 5 h postisolation. TUNEL reactivity of CD44hi CD8 T cells is represented in the histograms. Data in the
graph are a compilation of four experiments.
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transferred back into an infection-matched host i.p. or i.v. (Fig. 6A).
Splenocytes and PEC were isolated from the infection-matched
host mice at 36 h posttransfer. Thus, day 7 infected splenocytes
(which are highly apoptotic) were labeled and introduced into the
spleen or the PEC environment of a similarly infected host to
address whether the tissue environment contributed to CD8 T
cell survival. Donor P14CD8T splenocytes introduced directly
into the PEC environment via the i.p. route were less apoptotic
than the P14 CD8 T cells, which were present in the spleen
(Fig. 6B). A small number of donor P14 CD8 T splenocytes
inoculated intravenously were found in the PEC, and those also
were less apoptotic than the donor CD8 T cells which populated
the spleen (data not shown). Moreover, transferred P14 CD8 T
cells which were present in the PEC environment had higher ex-
pression ofCD27 thanP14CD8T cells present in the spleen (Fig.
6B). Thus, the in vivo PEC environment was not only promoting
survival of CD8T cells but also selectively retaining cells express-
ing memory markers.
FIG 5 Accumulation of CXCR3CD8 T cells in the inguinal lymph nodes on FTY720 treatment. (A) FTY720 treatment regimen. (B) Percentage and absolute
number of P14 CD8 T cells in inguinal lymph nodes (ILN) and PEC of FTY720- or control-treated mice at day 8 post-LCMV infection. (C) Percentage of
TUNEL P14 CD8 T cells in FTY720- and control-treated mice in inguinal lymph nodes (ILN), mesenteric lymph nodes (MLN), and PEC at day 8
post-LCMV infection. (D) Percentage of CXCR3 P14 CD8 T cells in FTY720- and control-treated mice in inguinal lymph nodes (ILN) and PEC at day 8
post-LCMV infection. (E) Percentage of CXCL9-expressing lymphocytes in spleen or PEC at day 8 post-LCMV infection. Plots were gated based on isotype
controls. (F) Fold change in CXCL9 and CXCL10 mRNAs in the total PEC leukocytes with respect to spleen leukocytes at day 7 post-LCMV infection. Data are
representative of two experiments with 3 mice in each experimental group. Percentages and error bars are represented
 SD.
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A potential complicating factor in these analyses was the pos-
sibility that apoptotic cells were more rapidly cleared in the pe-
ripheral tissues than in the spleen and lymph nodes. To test this
possibility, P14 CD8 T cells were adoptively transferred into
congenic hosts which were subsequently infected with LCMV.
Nucleotides released by apoptotic cells can be recognized by
phagocytic scavenger cells and promote clearance of apoptotic
cells (48). Apyrase, an enzyme which hydrolyzes nucleoside
triphosphates, can be used to prevent phagocytic clearance of
apoptotic cells (48). At day 8 postinfectionmice were treated with
apyrase or a succinate buffer control for 6 h, following which
splenocytes and PEC were isolated. Virus-specific CD8 T cells in
the PEC and spleen of apyrase-treated mice were, as expected,
more apoptotic than those of the control groups (Fig. 6C), thus
providing evidence that apyrase inhibited phagocytic clearance.
However, virus-specific, apoptosis-resistant CD8 T cells were
still enriched in the PEC compared to spleen in the apyrase-treated
group (Fig. 6C). This suggests that enhanced phagocytic clearance
was not a major contributor to tissue-dependent differences in
CD8 T cell apoptosis.
Increased frequency of apoptosis-resistant IL-2-producing
CD4 T cells in the nonlymphoid tissues. Survival and prolifer-
ation of CD8 T cells can also be influenced by other cell types
present in the tissue environment. CD4 T cell help has been
shown to be important for survival, maintenance, and generation
of functional memory CD8 T cells (49–52), and the absence of
CD4 T cells decreases the proportion and survival of CD8 T
cells at tissue effector sites (53, 54).We questioned whether CD4
T cells in the nonlymphoid tissues were also resistant to apoptosis
during resolution of the immune response. At day 8 post-LCMV
infection, lymphoid (spleen, inguinal lymph nodes, and mesen-
teric lymph nodes) and nonlymphoid (fat pad and PEC) tissues
were harvested and stained directly ex vivo for annexin V. CD44hi
CD4 T cells in the nonlymphoid tissues reacted much less with
the apoptotic marker annexin V than those in the lymphoid or-
gans (Fig. 7A). Day 8 LCMV-infected CD44hi CD4 T cells from
nonlymphoid tissues were also less TUNEL reactive than those in
lymphoid organs (Fig. 7B), further confirming the stability of
CD4 T cells in the nonlymphoid tissues. Therefore, similar to
CD8 T cells, CD4 T cells were also less apoptotic in the non-
lymphoid tissues.
We explored the possibility of CD4 T cells promoting CD8
T cell survival in the PEC. Transgenic LCMV GP61 epitope-spe-
cific CD4 T cells (SMARTA) were adoptively transferred into a
C57BL/6 congenic host, which was subsequently infected with
LCMV. At day 9 and day 15 post-LCMV infection, a higher per-
centage of IFN--producing virus-specific CD4 T cells was pres-
ent in the PEC than in the spleen (Fig. 7C).When stimulated with
cognate peptide, virus-specific CD4 T cells in the PEC made
much more IL-2 than those in the spleen (Fig. 7C). IL-2 is a T cell
FIG 6 In vivo PEC environment promotes CD8 T cell survival. (A) Schematic of experimental setup to test effect of in vivo tissue environment in promoting
survival of CD8 T cells. (B) Annexin V reactivity (top) and CD27 expression (bottom) on P14 CD8 T cells which were labeled and adoptively transferred
from a day 7 LCMV-infected donor to an infection-matched host as shown in the schematic in panel A. (C) Annexin V reactivity of P14 CD8 T cells in PEC
and spleen from day 8 LCMV-infected mice which were treated with apyrase or a buffer control for 6 h. Data are representative of two experiments with 3 mice
in each experiment. Percentages are represented
 SD.
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growth factor, and while it can promote AICD of T cells under
some circumstances (4), IL-2 therapy during contraction of the
immune response has been shown to increase CD8 T cell prolif-
eration and survival (55). Therefore, a higher proportion of virus-
specific CD4 T cells and CD8 T cells in the PEC are capable of
making IL-2, and low-level secretion of IL-2 could contribute to
the enhanced survival of CD8 T cells seen in the PEC environ-
ment. However, we were unable to show the presence of IL-2 in
the PEC environment directly ex vivo by ELISAs at day 7 post-
LCMV infection. We questioned if depleting CD4 T cells would
preferentially affect the survival of CD8 T cells in the PEC. A
modest effect was observed, in that CD8 T cell apoptosis in the
PEC trended higher at day 8 post-LCMV infection in mice de-
pleted of CD4 T cells at day 6 postinfection (18.1% 
 5.7%
TUNEL in controlmice versus 25.2%
 3.8%TUNEL in CD4-
depleted mice), but no change was observed in the spleen (34.3%

1.2% TUNEL in control mice versus 35.1%
 2.4% TUNEL in
CD4-depleted mice). This effect was quite modest but may indi-
cate that the increased proportion of IL-2-producingCD4T cells
in the PEC environment could account for some of the increased
resistance to apoptosis of virus-specific CD8 T cells in the PEC.
IL-2 signals are transduced by the high-affinity IL-2R, which is
FIG 7 Increased frequency of apoptosis-resistant IL-2-producing CD4 T cells in the nonlymphoid tissues. (A) Annexin V reactivity of CD44hi CD4 T cells in
lymphoid (spleen, inguinal lymphnodes [ILN],mesenteric lymphnodes [MLN]) andnonlymphoid (PEC and fat pad) tissues at day 8 post-LCMV infection. Five
mice were used for the experiment, and the experiment was done two times.Mean fluorescence intensity (MFI) for Annexin V reactivity on CD44hi CD4T cells
is listed in each histogram. (B) TUNEL reactivity of CD44hi CD4 T cells in lymphoid (spleen, inguinal lymph nodes, and mesenteric lymph nodes) and
nonlymphoid (PEC and fat pad) tissues at day 8 post-LCMV infection. Five mice were used for the experiment, and the experiment was done two times. (C)
Percentage of IL-2 IFN- double cytokine producers at day 9 and day 15 post-LCMV infection responding to GP61 stimulation in the PEC and spleen. Plots
are gated on CD4 TCR transgenic SMARTA T cells. (C) CD122 expression on P14CD8 T cells in PEC and spleen at day 9 and day 30 post-LCMV infection.
Data are representative of two independent experiments with 3 mice in each experiment. Plots were gated based on isotype control, and percentages are
represented
 SD.
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comprised of CD25 (IL-2R), CD122 (IL-2R), and CD132
(common  chain). CD25 expression is uniformly downregulated
in virus-specific CD8 T cells during resolution of the immune
response (56). However, intermediate-affinity IL-2R comprised
of CD122 and CD132 is sufficient for responsiveness to IL-2 and
IL-15 (57). We found a modest increase in virus-specific CD8 T
cells expressing CD122 in the PEC at day 9 post-LCMV infection
compared to spleen, and this difference was enhanced at day 30
post-LCMV infection (Fig. 7D). This might allow IL-2- and IL-
15-mediated CD8T cell survival in the PEC environment if trace
levels of these cytokines were made. Overall, these results indicate
that decreasedCD4T cell apoptosis and their enhanced ability to
produce IL-2 in the nonlymphoid tissues might be another factor
promoting stability of CD8 T cells in the peripheral tissue envi-
ronment.
DISCUSSION
T cells persist at high frequencies in nonlymphoid tissues after
resolution of the immune response, and these T cells are uniquely
geared to produce effector cytokines (58–62). The presence of
memory T cells at nonlymphoid tissue sites is critical for protec-
tion against secondary virus challenge (8–10, 61). We previously
showed that during and after silencing of the immune response,
LCMV-specific CD8 T cells in nonlymphoid tissues are more
resistant to apoptosis than those in the lymphoid organs (6), likely
explaining their abilities to survive in the periphery. Here, we
demonstrated this stability and the factors that contributed to this
resistance to cell death. It was first noted that cells in the periphery
were enriched for those expressing an antigenic signature (IL-
7Rhi, KLRG1lo, CD27hi, and CXCR3hi) that correlated with resis-
tance to apoptosis, regardless of whether the cells were isolated
from lymphoid organs or peripheral sites. Second, cells in the
periphery had enhanced expression of the transcription factor
TCF-1, which regulates Eomes and other genes leading to long-
term memory. Third, the chemokine receptor CXCR3, which
guides cells in their migration from lymph nodes to peripheral
sites, were markedly resistant to apoptosis, indicating a preferen-
tial entry of apoptosis-resistant cells into peripheral sites encoding
ligands for CXCR3. Fourth, adoptive transfer studies indicated
that the peripheral environment has a protective effect on trans-
ferred cells by an as yet undefined mechanism. The differences in
apoptotic cells between lymphoid andperipheral tissues, however,
could not be explained simply by differences in the rates of uptake
of these cells by phagocytes, as shown by apyrase blocking studies.
Thus, apoptosis-resistant CD8 T cells seem to leave the spleen
and lymph nodes and get into the peripheral sites, where they
encounter an environment that sustains their survival, enabling
them to be present to respond to a secondary challenge. Possible
factors promoting survival in the peritoneal environment include
IL-2-producing CD4 T cells, which are similarly resistant to
apoptosis.
The mechanisms underlying tissue-dependent differences in
CD8 T cell apoptosis were addressed in this study. Higher pro-
portions of virus-specificCD8T cells in the nonlymphoid tissues
expressed surfacemarkers that correlated with an apoptosis-resis-
tant phenotype. CD8 T cells which are IL-7Rhi and KLRG1lo are
thought to preferentially becomememory cells (11–13), and these
were found in higher proportions in nonlymphoid tissues (Fig.
2A). IL-7 therapy during contraction of the immune response
enhances the generation of memory CD8 T cells (63). IL-7 sig-
naling induces STAT-5 phosphorylation, which is known to be
associated with survival of effector andmemory CD8 T cells (64,
65). We found that a higher proportion of virus-specific CD8 T
cells in the PEC exhibited STAT-5 phosphorylation in response to
IL-7 directly ex vivo than the spleen counterparts (49% in the PEC
versus 31% in the spleen), so constitutively produced IL-7 may
contribute to the survival of virus-specific CD8 T cells in the
PEC. CD27 is another molecule that sustains survival of virus-
specific CD8 T cells by inducing autocrine IL-2 production (17).
A higher proportion of virus-specific CD8 T cells in the PEC
expressed CD27, and these were also less apoptotic (Fig. 2B).
Stimulation through CD27 requires the presence of its costimula-
tory ligand CD70, which is expressed on dendritic cells (DCs), B
cells, and activated CD4 and CD8 T cells. A study by another
group showed that blocking CD70-CD27 costimulation during
acute LCMV infection decreased the CD8 T cell response and
IL-7R expression on virus-specific CD8 T cells (66). We found
that at day 9 post-LCMV infection, total PEC leukocytes had a
higher expression of CD70 than spleen leukocytes (data not
shown). Thus, sustainedCD27 stimulation due to continued pres-
ence of CD70 cells in the PEC environment might promote sur-
vival of virus-specific CD8 T cells. T cell apoptosis in lung and
liver sites has been studied by other groups (33, 34, 67). The liver
is problematic to analyze because it is thought to be a graveyard for
apoptotic cells. T cells in the lung, however, are very resistant to
apoptosis, and the collagen binding11 integrinVLA-1 has been
shown to be important inmaintenance and survival of influenzaA
virus-specific CD8 T cells in lungs (67). However, we did not
findVLA-1 to be highly expressed onLCMV-specificCD8T cells
in the PEC or spleen, suggesting that different mechanisms might
regulate tissue-dependent survival in different tissues and during
different viral infections.
Initially we performed experimentswithmice immunizedwith
serum-containing LCMV stocks. We found that in in vitro assays,
CD4 T cells from the PEC but not spleen responded strongly to
serum, thereby inducing IL-2 production that contributed to
CD8 T cell survival in the PEC but not the spleen. Serum-free
LCMV stocks were thus used for the experiments in the current
study. Since CD4 T cells in the PEC had a dramatic response to
serum antigen, we can speculate that a similar response to limited
amounts of viral antigen in the PECmight promote CD4 T cell-
dependent CD8 T cell survival in the PEC. Influenza virus-de-
rived antigens are known to be presented for a prolonged period in
the lung after apparent resolution of infection (68), and whether
similar persistence of LCMV antigen contributes to T cell survival
is not clear. However, we found that tissue-dependent differences
inCD8T cell apoptosis persisted even if the peritoneal cavity was
not the initial site for antigen delivery. In mice challenged with
LCMVvia the i.v. route, the influx of activated CD8T cells in the
PEC was decreased, but CD8 T cells in the PEC were still more
resistant to apoptosis than those in the spleen (data not shown).
Transcription factors can regulate CD8 T cell effector-mem-
ory fate decisions. We show that a higher proportion of CD8 T
cells in the PEC express large amounts of TCF-1, which positively
correlated with T cell memory potential and survival (Fig. 3A, B,
and C). By using Tcf7/ mice, we showed that TCF-1 was rela-
tively more important in promoting survival of CD8 T cells in
the peritoneum than in the spleen during resolution of the im-
mune response. Our results indicate that loss of TCF-1 does not
have any additive effect on T cell apoptosis in the spleen (since
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they are contracting due to cytokine deprivation and apoptotic
signals), but TCF-1 expression is relatively more important in
promoting T cell survival in the PEC during resolution of the
immune response. We observed that by day 30 post-LCMV, in-
fection nearly 93% of virus-specific CD8 T cells in the PEC were
TCF-1 positive (Fig. 3A) and 62% of these were IL-7Rhi KLRG1lo
(MPEC) (data not shown), suggesting that increased survival in
nonlymphoid tissues was not simply due to the presence of a
higher proportion ofmemory-precursor effector cells. Expression
of TCF-1 can be modulated byWnt ligands and by T cell receptor
(TCR) and cytokine signals (25, 69, 70). It has been suggested that
Wnt proteins might induce the TCF-1–Eomes–IL-2Rb axis to en-
hance cytokine responsiveness in memory CD8 T cells (25).
How do virus-specific CD8 T cells maintain higher TCF-1 ex-
pression in the PEC? The PEC environment is enriched in macro-
phages and dendritic cells, which in vitro are known to produce
Wnt5a, which induces the noncanonical Wnt pathway (71). Al-
ternatively, it is possible that TCF-1-expressing cells might pref-
erentially populate the peritoneal cavity. Future studies will need
to define the underlying mechanism for the biased recruitment
and/or maintenance of TCF-1hi cells in nonlymphoid tissues.
T cells migrate into tissue effector sites postactivation to elim-
inate foreign antigens, andwe provide evidence that nonapoptotic
CXCR3 CD8 T cells accumulated in the lymph nodes if their
egress was blocked by FTY720 treatment. Studies done by other
groups have shown that CXCR3-deficient CD8 T cells undergo
decreased contraction and form better memory populations (20,
72). The explanation for this may be complex, but because
CXCR3-deficient T cells do not efficiently localize to sites of anti-
gen and inflammation, they may undergo abnormal differentia-
tion that renders them less sensitive to apoptosis. An alternate
explanation consistent with our results could be that apoptosis-
resistant T cells that lack CXCR3 accumulate in the lymphoid
organs, and the accumulation of those apoptosis-resistant T cells
retards the contraction effect. CXCR3CD8T cells are known to
migrate in response to IFN--inducible chemokines CXCL9 and
CXCL10. CXCL9 and CXCL10 are produced by activated macro-
phages and DCs, and we found that the PEC environment ex-
pressed these chemokines. Thus, during resolution of the immune
response, nonapoptotic memory phenotype CD8 T cells likely
migrate into nonlymphoid tissues. This trafficking pattern, in
conjunction with tissue-intrinsic differences in promoting cell
survival, provides an attractive mechanism for promoting long-
lived immunity at nonlymphoid tissues.
Thus, multiple mechanisms seem to account for tissue-depen-
dent differences in CD8 T cell apoptosis seen during resolution
of the immune response. These mechanisms would work in con-
junction to promote survival and overall maintenance of CD8 T
cell populations in nonlymphoid tissues. The presence of func-
tional long-lived memory CD8 T cells at nonlymphoid tissue
effector sites would ensure a productive response upon an en-
counter with the antigen providing protection against secondary
virus challenge.
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